News about "drug discovery"

Mankind Pharma Partners with Denovo Sciences to Accelerate AI-Driven Drug Discovery

Mankind Pharma Partners with Denovo Sciences to Accelerate AI-Driven Drug Discovery

The collaboration between Mankind Pharma and Denovo Sciences launches AI-powered drug discovery to accelerate research timelines and improve lead candidate quality.

Drug Discovery | 02/07/2026 | By News Bureau

Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research

Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research

Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).

Drug Discovery | 16/06/2026 | By News Bureau

GVRP and Steps Biosciences Launch Advanced Formulations Research Centre in Bengaluru

GVRP and Steps Biosciences Launch Advanced Formulations Research Centre in Bengaluru

GVRP and Steps Biosciences have inaugurated the GVRP StepsBio Research Centre (GSRC) at Bengaluru’s Lifescapes life sciences cluster, strengthening India’s pharmaceutical innovation ecosystem with advanced facilities for complex formulations, sterile injectables, analytical testing and AI-enabled drug development.

Drug Discovery | 06/06/2026 | By News Bureau

Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration

Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration

Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.

Drug Discovery | 20/03/2026 | By News Bureau 119

Dalriada Drug Discovery, Topos Bio Partner to Advance AI-Driven Drug Discovery for Intrinsically Disordered Proteins

Dalriada Drug Discovery, Topos Bio Partner to Advance AI-Driven Drug Discovery for Intrinsically Disordered Proteins

Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.

Drug Discovery | 18/03/2026 | By News Bureau 162

Roche Boosts AI Muscle with Nvidia Chip Expansion to Accelerate Drug Discovery

Roche Boosts AI Muscle with Nvidia Chip Expansion to Accelerate Drug Discovery

Swiss pharma major Roche has significantly expanded its artificial intelligence (AI) capabilities by deploying thousands of advanced GPUs from Nvidia, marking one of the largest AI infrastructure investments in the pharmaceutical sector.

Drug Discovery | 17/03/2026 | By Darshana 140

Syngene Partners with Johns Hopkins University for Early Drug Discovery

Syngene Partners with Johns Hopkins University for Early Drug Discovery

The collaboration between Syngene International and John Hopkins University is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research.

Drug Discovery | 13/02/2026 | By News Bureau 170

Illumina Completes USD 350 Million Acquisition of SomaLogic to Expand Multiomics and Proteomics Capabilities

Illumina Completes USD 350 Million Acquisition of SomaLogic to Expand Multiomics and Proteomics Capabilities

Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.

Drug Discovery | 02/02/2026 | By News Bureau 937

FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes

FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes

Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.

Drug Discovery | 22/01/2026 | By News Bureau 237

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer

Adaptive Biotechnologies has signed two immune receptor licensing agreements with Pfizer, covering a T-Cell Receptor (TCR) discovery collaboration in rheumatoid arthritis and access to Adaptive’s proprietary TCR-antigen datasets for immunology R&D.

Drug Discovery | 16/12/2025 | By News Bureau 237


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members